AmerisourceBergen (ABC) Set to Announce Earnings on Monday

AmerisourceBergen (NYSE:ABC) is scheduled to be posting its quarterly earnings results before the market opens on Monday, January 29th. AmerisourceBergen has set its FY18 guidance at $5.90-6.15 EPS.

AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. The company had revenue of $39.12 billion during the quarter, compared to the consensus estimate of $40.10 billion. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. The firm’s revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.30 EPS. On average, analysts expect AmerisourceBergen to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

AmerisourceBergen (NYSE:ABC) opened at $100.06 on Monday. The stock has a market capitalization of $21,821.29, a P/E ratio of 54.09, a P/E/G ratio of 1.69 and a beta of 0.99. The company has a debt-to-equity ratio of 1.83, a quick ratio of 0.48 and a current ratio of 0.91. AmerisourceBergen has a 52 week low of $71.90 and a 52 week high of $101.85.

A number of research analysts recently issued reports on the company. Zacks Investment Research upgraded AmerisourceBergen from a “hold” rating to a “buy” rating and set a $111.00 price objective for the company in a research note on Thursday. Evercore ISI initiated coverage on AmerisourceBergen in a research note on Thursday, January 4th. They issued an “outperform” rating and a $105.00 price target for the company. Leerink Swann set a $105.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a research note on Tuesday, January 2nd. Goldman Sachs Group upgraded AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday, December 15th. Finally, Cowen set a $107.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a research note on Tuesday, December 12th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $96.39.

In other news, Director Richard W. Gochnauer sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 10th. The stock was sold at an average price of $96.54, for a total transaction of $193,080.00. Following the sale, the director now directly owns 12,947 shares of the company’s stock, valued at approximately $1,249,903.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $74.28, for a total value of $861,648.00. Following the sale, the chief financial officer now directly owns 40,326 shares in the company, valued at $2,995,415.28. The disclosure for this sale can be found here. Insiders sold a total of 203,823 shares of company stock valued at $17,145,148 over the last 90 days. 27.40% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/01/22/amerisourcebergen-abc-set-to-announce-earnings-on-monday.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Earnings History for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply